Mobile Site ›

Biomarkers of Acute Renal Failure



Subscribe

Receive notification when new Hot Topics are published:

Mayo Clinic Goals

Slide 24

August 2009

Currently, the Mayo Clinic Renal Function Laboratory is actively developing methodology for monitoring these and other urinary biomarkers of kidney injury. We have validated a rapid ELISA test for NGAL. Turnaround time for this is approximately 1 hour. As the literature evolves, we plan to develop additional biomarkers. A potential strategy might be to develop a multiplexed panel of acute kidney injury biomarkers that could be used to stage patients at risk. It’s also possible that many of these markers will have utility for following patients with chronic kidney disease in order to gauge the effectiveness of ongoing therapies to slow progression.

Mayo Clinic Goals

 


Jump to section:


Key